Clinical Trial: The Efficacy, Safety, And Tolerability Of Donepezil HCl (E2020) In Patients With CADASIL Who Have Cognitive Impairment

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: An 18-Week, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Of The Efficacy, Safety, And Tolerability Of Donepezil HCl (E2020) In Patients With C

Brief Summary: This is an 18-week, prospective, multi-center, randomized, double-blind, placebo-controlled, (1:1) parallel-group study.

Detailed Summary:
Sponsor: Eisai Limited

Current Primary Outcome: Cognitive function.

Original Primary Outcome: cognitive function

Current Secondary Outcome:

Original Secondary Outcome:

  • other cognitive assessments
  • functional assessments
  • safety
  • tolerability


Information By: Eisai Inc.

Dates:
Date Received: February 17, 2005
Date Started: February 2005
Date Completion:
Last Updated: November 2, 2015
Last Verified: November 2015